Table 1 Demographic and clinical characteristics of participants
From: Synergistic interaction of high blood pressure and cerebral beta-amyloid on tau pathology
Characteristics | History of hypertension (n = 34) | No history of hypertension (n = 34) | p-value |
|---|---|---|---|
Age in years, mean (SD) | 72.2 (8.0) | 70.7 (6.7) | 0.425 |
Females, (%) | 21 (62) | 19 (56) | 0.622 |
Education in years, mean (SD) | 12.1 (4.2) | 11.9 (4.0) | 0.906 |
APOE4 carrier, (%) | 7 (21) | 5 (15) | 0.525 |
SBP in mmHg, mean (SD) | 128.8 (14.9) | 124.3 (19.4) | 0.281 |
DBP in mmHg, mean (SD) | 78.1 (10.2) | 75.0 (11.9) | 0.253 |
Onset age of hypertension in years, mean (SD) | 60.6 (8.6) | - | Â |
Duration of hypertension in years, mean (SD) | 11.6 (7.0) | - | Â |
Treatment with antihypertensive medication, (%) | 32 (94) | - | Â |
Diabetes mellitus, (%) | 12 (35) | 8 (24) | 0.287 |
Coronary artery diseasea, (%) | 4 (12) | 1 (3) | 0.356 |
Dyslipidemia, (%) | 17 (50) | 12 (35) | 0.220 |
Stroke, (%) | 1 (3) | 0 | Â |
TIA | 0 | 0 | Â |
VRS, mean (SD) | 1.00 (0.78) | 0.62 (0.78) | 0.047 |
Global WMH volume in mL, mean (SD) | 17.53 (15.04) | 12.00 (13.00) | 0.108 |